Thermo Fisher Scientific EV/EBITDA Ratio 2011-2026 | TMO

Annual EV/EBITDA Ratio Thermo Fisher Scientific

2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011
19.3	23	24.3	20.7	22.4	18	17.2	19.5	18.8	13.8	13

All numbers in USD currency

Indicator range from annual reports

Maximum	Minimum	Average
24.3	13	19.1

EV/EBITDA Ratio of other stocks in the Diagnostics research industry

Issuer	EV/EBITDA Ratio	Price	% 24h	Market Cap	Country
Centogene N.V. CNTG	0.387	-	-6.23 %	$ 30.6 M	Germany
Agilent Technologies A	27.4	$ 114.84	-0.55 %	$ 34.9 B	USA
Aspira Women's Health AWH	-2.63	-	-6.19 %	$ 10.5 M	USA
Biocept BIOC	-26.9	-	-13.05 %	$ 7.29 M	USA
Check-Cap Ltd. CHEK	-0.674	-	-	$ 9.42 M	Israel
Oxford Immunotec Global PLC OXFD	-73.4	-	-	$ 562 M	Britain
Akumin AKU	28.1	-	-17.87 %	$ 25.9 M	Canada
CareDx, Inc CDNA	-100	$ 17.82	-2.68 %	$ 950 M	USA
Burning Rock Biotech Limited BNR	-1.51	$ 16.3	0.62 %	$ 175 M	China
Accelerate Diagnostics AXDX	-5.56	-	-61.36 %	$ 2.46 M	USA
Global Cord Blood Corporation CO	-3.52	-	-	$ 399 M	China
Fluidigm Corporation FLDM	-13.6	-	1.08 %	$ 308 M	USA
Genetic Technologies Limited GENE	-2.67	-	-	$ 7.1 B	Australia
Genetron Holdings Limited GTH	-2.67	-	0.12 %	$ 80.1 M	China
Exact Sciences Corporation EXAS	-20.8	-	-	$ 19.8 B	USA
PRA Health Sciences, Inc. PRAH	20.8	-	-	$ 10.7 B	USA
DermTech DMTK	-2.44	-	-11.32 %	$ 2.94 M	USA
Biodesix BDSX	-4.25	$ 15.36	1.92 %	$ 1.99 B	USA
Enzo Biochem ENZ	58.3	-	-8.98 %	$ 14.8 K	USA
Heska Corporation HSKA	141	-	-	$ 1.31 B	USA
HTG Molecular Diagnostics HTGM	-1.42	-	-20.0 %	$ 1.06 M	USA
QIAGEN N.V. QGEN	13.2	-	-	$ 10.6 B	Niderland
Co-Diagnostics CODX	3.62	$ 4.4	101.83 %	$ 5.85 M	USA
Anixa Biosciences ANIX	-2.25	$ 2.59	1.57 %	$ 84.1 K	USA
Biomerica BMRA	-6.24	$ 2.17	-	$ 4.98 M	USA
BioNano Genomics BNGO	-7.71	$ 1.15	-4.17 %	$ 6.26 M	USA
Charles River Laboratories International CRL	22	$ 168.22	-3.26 %	$ 8.34 B	USA
Castle Biosciences CSTL	-21.2	$ 24.73	-0.44 %	$ 687 M	USA
Danaher Corporation DHR	20.1	$ 192.12	0.52 %	$ 137 B	USA
Celcuity CELC	-2.38	$ 114.22	1.41 %	$ 5.34 B	USA
DexCom DXCM	39.5	$ 63.21	1.59 %	$ 24.7 B	USA
Fulgent Genetics FLGT	2.58	$ 16.42	-2.38 %	$ 496 M	USA
Chembio Diagnostics CEMI	-1.23	-	0.22 %	$ 16.8 M	USA
Guardant Health GH	-28.8	$ 89.66	-4.44 %	$ 11.2 B	USA
Quest Diagnostics Incorporated DGX	5.51	$ 198.96	0.91 %	$ 22.1 B	USA
Motus GI Holdings MOTS	0.351	-	-34.28 %	$ 263 K	Israel
ICON Public Limited Company ICLR	38	$ 109.62	-4.0 %	$ 9.04 B	Irlanda
Illumina ILMN	70.5	$ 127.74	0.28 %	$ 20.3 B	USA
IQVIA Holdings IQV	24.1	$ 170.72	-1.47 %	$ 29.3 B	USA
Interpace Biosciences IDXG	-6.02	$ 1.97	0.63 %	$ 8.72 M	USA
Laboratory Corporation of America Holdings LH	8.7	$ 274.46	0.27 %	$ 22.8 B	USA
Lantheus Holdings LNTH	-187	$ 75.89	-0.28 %	$ 5.12 B	USA
Medpace Holdings MEDP	30.7	$ 496.0	-0.47 %	$ 14.3 B	USA
Invitae Corporation NVTA	-10.7	-	-	$ 21.2 M	USA
Mettler-Toledo International MTD	827	$ 1 266.63	0.53 %	$ 26.1 B	Schweiz
Myriad Genetics MYGN	-17.2	$ 4.67	-1.68 %	$ 432 M	USA
ENDRA Life Sciences NDRA	0.831	$ 4.74	1.07 %	$ 3.73 M	USA
NeoGenomics NEO	-33.5	$ 8.02	0.25 %	$ 1.03 B	USA
Neogen Corporation NEOG	40.3	$ 9.56	1.59 %	$ 2.07 B	USA
National Research Corporation NRC	21	$ 17.33	0.99 %	$ 388 M	USA